Mawi DNA Technologies Announces New Distribution Partnership…
READ MOREA deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The iSWAB-Microbiome-EL has been proven to safely collect and transport samples suspected of containing the infection and has…
READ MORETop Reasons to Ditch Your Current VTM. Upgrade your Viral Transport Media
Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior option: 1. FDA Approved* 2. Skip the RNA extraction step in PCR workflow 3. Inactivates viruses and other…
READ MOREAlternative to Blood Samples For Cancer Patients
Immunocompromised patients are often subjected to blood testing at a weekly or biweekly schedule to monitor treatment and health screenings. Mawi understands that these patients may be weary of constant visits to a hospital or clinic due to exposure of potential pathogens. We offer an…
READ MORELooking to Improve Your Success Rate Downstream for DNA Sequencing
When it comes to whole genome sequencing (WGS), customers are reporting a success rate of greater than 95% when utilizing Mawi DNA’s iSWAB-DNA sample collection devices. Here’s what’s different and why it matters. Bacterial DNA in WGS leads to reduced sequencing coverage, false positive variations, bias…
READ MORE4 vs. 1 Achieve More With Less
Mawi’s iSWAB-DNA was used to collect saliva samples from parents and children for Whole Exome Sequencing. Two take away messages from this paper: We enable whole exome sequencing One iSWAB sample collection (iSWAB-DNA-250) vs. Four of DNA Genotek (OGR-175, OGR-500, OGR-525, and OGR-57) View Protocol
READ MOREAppreciating Women in STEM
The month of March is National Women’s Month and Mawi DNA is celebrating the amazing women on our team that are bringing innovation to life. Our diverse team comes together everyday to push the boundaries of continuously innovating biosampling collection technology. At Mawi DNA the…
READ MOREInnovate Further with High Quality DNA Samples
iSWAB™-DNA Quick Facts Gentle lytic buffer Non-Toxic and alcohol-free device High recovery of high molecular weight gDNA Insignificant quantities of bacterial DNA contamination Compatible with microarrays and Next Generation Sequencing Stable at room temperature for ~3 years The Mawi team is here to contribute to your…
READ MOREThe Safest Microbial Buffer on the Market
The iSWAB™-Microbiome (iSWAB™-MB) is a non-toxic, stabilizing sample device designed to maintain the status quo of samples at the time of collection, providing a representative snapshot of the microbial community that remains unchanged from the point of collection to processing.
READ MOREMawi DNA Awarded Leading Innovators of Biosample Collection Technology 2022
The Global Health & Pharma (GH&P) Magazine awarded Mawi DNA Technologies with the 2022 Leading Innovators of Biosample Collection Technology Award. Mawi DNA is honored to be recognized for this achievement and continues to develop innovative technologies for universal sample collection. “I strongly believe that science is…
READ MOREAnnouncing Mawi DNA’s Joint venture with our local partner BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market.
Announcing Mawi DNA's joint venture with BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market. This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA's strategy and vision are centered around ensuring health needs…
READ MORE